Why the study?
Does chronotherapy improve 24-hour blood pressure control and reduce adverse outcomes in hypertensive patients compared to standard once-daily therapies?
Does chronotherapy improve 24-hour blood pressure control and reduce adverse outcomes in hypertensive patients compared to standard once-daily therapies?
Chronotherapy for hypertension may offer improved 24-hour blood pressure control and mitigate the high risk of cardiovascular events associated with the early morning blood pressure surge.
Answers are grounded in this paper and cite their sources.
Should not alter antihypertensive timing in practice; leaves open chronotherapy benefits in prospective outcome trials.
Blood pressure and heart rate follow a circadian rhythm, peaking between the hours of 6:00 AM and 12:00 noon. The early morning surge in blood pressure has been linked to an increased occurrence of acute myocardial infarction, sudden cardiac death, silent ischemia, and stroke during these critical hours. Specifically, there is a 40% higher risk of heart attack, a 29% increased risk of cardiac death, and a 49% increased risk of stroke during this period.1 From a clinical standpoint, optimal antihypertensive therapy needs to provide 24-hour blood pressure control. Unfortunately, most of the currently available once-daily therapies do not deliver medications synchronized with the body's circadian rhythm. Chronotherapeutic drug formulations, for this reason, may provide an added benefit to the treatment of hypertensive patients, as these agents offer 24-hour blood pressure control from a single daily dose and provide improved blood pressure control during the early morning BP surge.2 Antihypertensive regiments that provide improved control of blood pressure during high-risk periods may reduce adverse outcomes and sequelae, particularly in high-risk patients.3 It is critical for specialist to evaluate the role of chronotherapy in hypertension management, thereby enabling them to make informed treatment decisions, and advocate to primary care providers, based upon their assessment of the body of evidence in the professional literature. Furthermore, selecting drug treatments that correlate with specific circadian variations in BP may provide alternative treatment options for improving the management of hypertensive patients.
No takes yet. Share an insight, caveat, or question.
J DOUGLAS (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: